UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Leukemia, 2016-04, Vol.30 (4), p.929-936

2016

Volltextzugriff (PDF)

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

Leukemia, 2010-03, Vol.24 (3), p.512-520

2010

Volltextzugriff (PDF)

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Leukemia, 2007-05, Vol.21 (5), p.956-964

2007

Volltextzugriff (PDF)

Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic

Cytometry. Part B, Clinical cytometry, 2010, Vol.78B (S1), p.S47-S60

2010

Volltextzugriff (PDF)

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

Rheumatology (Oxford, England), 2008-04, Vol.47 (4), p.552-553

2008

Volltextzugriff (PDF)

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Leukemia, 2013-01, Vol.27 (1), p.142-149

2013

Volltextzugriff (PDF)

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens

Leukemia, 2006-12, Vol.20 (12), p.2102-2110

2006

Volltextzugriff (PDF)

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL

Leukemia, 2017-10, Vol.31 (10), p.2085-2093

2017

Volltextzugriff (PDF)

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

Leukemia, 2017-11, Vol.31 (11), p.2416-2425

2017

Volltextzugriff (PDF)

The PNH phenotype cells that emerge in most patients after CAMPATH‐1H therapy are present prior to treatment

British journal of haematology, 1999-10, Vol.107 (1), p.148-153

1999

Volltextzugriff (PDF)

High-Producer Haplotypes of Tumor Necrosis Factor Alpha and Lymphotoxin Alpha Are Associated With an Increased Risk of Myeloma and Have an Improved Progression-Free Survival After Treatment

Journal of clinical oncology, 2000-08, Vol.18 (15), p.2843-2851

2000

Volltextzugriff (PDF)

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage

British journal of haematology, 1997-04, Vol.97 (1), p.46-55

1997

Volltextzugriff (PDF)

In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA‐5 and CD45 expression

British journal of haematology, 2001-06, Vol.113 (3), p.794-802

2001

Volltextzugriff (PDF)

Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve

British journal of haematology, 2001-09, Vol.114 (4), p.937-943

2001

Volltextzugriff (PDF)

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Blood, 2001-07, Vol.98 (1), p.29-35

2001

Volltextzugriff (PDF)

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Blood, 2002-07, Vol.100 (2), p.635-639

2002

Volltextzugriff (PDF)

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma

Leukemia, 2007-09, Vol.21 (9), p.2046-2049

2007

Volltextzugriff (PDF)

Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re‐treatment

Arthritis and rheumatism, 2010-05, Vol.62 (5), p.1273-1279

2010

Volltextzugriff (PDF)

Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders

Clinical lymphoma, myeloma and leukemia, 2011-02, Vol.11 (1), p.176-179, Article 176

2011

Volltextzugriff (PDF)

Association between clinical response and CIRCULATING B cell subsets during B cell depletion therapy for systemic lupus erythematosus

Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 2), p.A66-A67

2011

Volltextzugriff (PDF)

Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults

Leukemia, 2006-04, Vol.20 (4), p.728-729

2006

Volltextzugriff (PDF)

Assessment of IgH PCR strategies in multiple myeloma

Journal of clinical pathology, 1996-08, Vol.49 (8), p.672-675

1996

Volltextzugriff (PDF)

Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma

British journal of haematology, 2001-02, Vol.112 (2), p.388-391

2001

Volltextzugriff (PDF)

Controversies surrounding the clonogenic origin of multiple myeloma

British journal of haematology, 2000-07, Vol.110 (1), p.240-241

2000

Volltextzugriff (PDF)

Isotype class switching and the pathogenenesis of multiple myeloma

Hematological oncology, 2002-06, Vol.20 (2), p.75-85

2002

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(250)

Erscheinungsjahr

n.n

Thema

Humans
(134)
Life Sciences & Biomedicine
(132)
Science & Technology
(132)
Hematology
(81)
Male
(59)
Middle Aged
(59)
Female
(58)
Biological And Medical Sciences
(56)
Medical Sciences
(55)
Aged
(53)
Flow Cytometry
(47)
Adult
(44)
Oncology
(38)
Treatment Outcome
(30)
Hematologic And Hematopoietic Diseases
(29)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Prognosis
(25)
Multiple Myeloma - Genetics
(23)
Rituximab
(23)
Aged, 80 And Over
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(68)
British Journal Of Haematology
(38)
Annals Of The Rheumatic Diseases
(16)
Cytometry. Part B, Clinical Cytometry
(11)
Leukemia
(11)
Clinical Lymphoma & Myeloma
(7)
Arthritis And Rheumatism
(6)
Law Teacher
(6)
Haematologica
(5)
Hematological Oncology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

The PNH phenotype cells that emerge in most patients after CAMPATH‐1H therapy are present prior to treatment

High-Producer Haplotypes of Tumor Necrosis Factor Alpha and Lymphotoxin Alpha Are Associated With an Increased Risk of Myeloma and Have an Improved Progression-Free Survival After Treatment

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage

In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA‐5 and CD45 expression

Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma

Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re‐treatment

Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders

Association between clinical response and CIRCULATING B cell subsets during B cell depletion therapy for systemic lupus erythematosus

Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults

Assessment of IgH PCR strategies in multiple myeloma

Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma

Controversies surrounding the clonogenic origin of multiple myeloma

Isotype class switching and the pathogenenesis of multiple myeloma

Suchergebnisse filtern